Our Recommendations
- Mejores prácticas para la atención de pacientes con tuberculosis (2017)
- WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update (2016)
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice (2019)
- Field Guide for the Management of Drug-Resistant Tuberculosis (2018)
New Publications
- Community tuberculosis screening, testing and care, Uganda (2024)
- WHO operational handbook on tuberculosis: module 6: tuberculosis and comorbidities, 2nd ed (2024)
- Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed (2023)
- Roadmap towards ending TB in children and adolescents, 3rd ed (2023)
- The use of next-generation sequencing for the surveillance of drug-resistant tuberculosis: an implementation manual (2023)
Filter
310
Featured
Recommendations
32
New Publications
30
Language
Document type
No document type
204
Guidelines
41
Manuals
23
Studies & Reports
15
Fact sheets
12
Training Material
8
Strategic & Response Plan
3
Online Courses
2
Situation Updates
1
Videos
1
Countries / Regions
Russia
7
Eastern Europe
5
Colombia
4
El Salvador
4
Western and Central Europe
4
Tajikistan
3
Ukraine
3
Argentina
3
India
3
Armenia
2
Global
2
Latin America and the Carribbean
2
Germany
2
Brazil
2
Ecuador
2
Kenya
1
Chile
1
Nigeria
1
Albania
1
Peru
1
Mozambique
1
USA
1
Africa
1
Asia
1
South–East Asia Region
1
South Africa
1
Uganda
1
Moldova
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
76
Countries
24
Pharmacy & Technologies
13
Public Health
4
Key Resources
2
Capacity Building
1
Women & Child Health
1
Guide des éléments essentiels pour une bonne pratique - Première édition 2019
Ce guide a été conçu afin d’apporter les informations nécessaires à une prise en charge pratique et exhaustive des personnes atteintes de diabète et de tuberculose. Il s’appuie sur les résultats d’étude...
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In...
TEchnical Note
Describir el comportamiento epidemiológico de comorbilidades en
pacientes diagnosticados con tuberculosis de una institución prestadora de servicios
de salud (IPS) de Colombia, durante 2016 a 2019.
Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income CountriesThe practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide.
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Healthy me, healthy us: a guide for community members about good health and staying healthy with chronic illness
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tuberculosis (MDR-TB) treatment shows that newer and repurposed drugs produced better outcomes and fewer deaths than older treatments.
The meta-analysis...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
Презентация о туберкулезе и диабете
Цей документ описує кроки, необхідні для визначення скоригованого інтервалу QT (QTc) в
ході моніторингу ЕКГ пацієнтів, які отримують препарати для лікування ХР ТБ, що...
Презентация на тему значимости скрининга больных с лекарственно-устойчивым туберкулезом на гепатит С. Как лучше всего лечить этих пациентов от гепатита С.
